Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Cefuroxime Axetil Tablets Ip 250 Mg

₹ 2,750/Box

Strength250mg
Pack Size10*10 Tablets
Pack TypeBox
BrandVAXTIL-250
Shelf Life24 Months
UsageTo treat bacterial infections
AvailabilityIn Stock
VAXTOL-250 is used to treat certain infections caused by bacteria, such as bronchitis(infection of the airway tubes leading to the lungs); gonorrhea (a sexually transmitted disease); Lyme disease (an infection that may develop after a person is bitten by a tick); and infections of the skin, ears, sinuses, throat, tonsils,, and urinary tract. Cefuroxime is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria.

Find products similar to Cefuroxime Axetil Tablets Ip 250 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Cefuroxime Axetil Tablets Ip 250 Mg-1Cefuroxime Axetil Tablets Ip 250 Mg-2

About the Company

GST Registration Date
Jan 2018
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Aug 2016
GST
06**********1Z2

Established in the year of 2018, We “Ryze Lifecare” are Trader and Wholesaler of an Herbal Medicine, Dry Syrup, Ointment, Injection, Eye Drops, Nasal Drops, Pharmaceutical Syrup, and much more. Cough of different kinds and severities can be treated with Syrups, like Kofzime-A, Kofzime-T and Kofzime-D,etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.


For our accomplishment story, we are grateful to our Mr.Varun Sandal, whose continual backing and direction have been useful to us for attaining exponential development in the current market...